• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Laminar organization of cholinergic circuits in human frontal cortex in Alzheimer's disease and aging.

作者信息

DeKosky S T, Scheff S W, Markesbery W R

出版信息

Neurology. 1985 Oct;35(10):1425-31. doi: 10.1212/wnl.35.10.1425.

DOI:10.1212/wnl.35.10.1425
PMID:4033925
Abstract

Cholinergic enzyme activity (choline acetyltransferase, CAT; acetylcholinesterase, AChE) and muscarinic cholinergic receptor density were measured in frontal cortex (Brodmann's area 9) of normal patients over the life span and in brains of patients with Alzheimer's disease (AD). CAT, but not AChE activity, declined with normal aging. Significant loss of CAT and AChE activity occurred in the AD brains, but later onset AD was associated with less severe loss of frontal cortex CAT activity. The majority of normal CAT activity resided in lamina I, II, and upper lamina III; CAT loss in AD resulted in large losses from all depths, most notably the upper cortical layers. AChE did not precisely correspond to the localization of CAT; loss of AChE in AD was consistent across all six laminae. No differences were seen in muscarinic cholinergic receptor binding between AD and age-matched controls; the distribution of binding was equal in all layers of normal frontal cortex, and no laminar differences were detected in distribution of cholinergic receptors between normal and AD samples.

摘要

相似文献

1
Laminar organization of cholinergic circuits in human frontal cortex in Alzheimer's disease and aging.
Neurology. 1985 Oct;35(10):1425-31. doi: 10.1212/wnl.35.10.1425.
2
Intralaminar distribution of neurotransmitter-related enzymes in cerebral cortex of Alzheimer's disease.阿尔茨海默病大脑皮质中神经递质相关酶的板内核分布
Gerontology. 1987;33(3-4):197-202. doi: 10.1159/000212876.
3
Cortical biopsy in Alzheimer's disease: diagnostic accuracy and neurochemical, neuropathological, and cognitive correlations. Intraventricular Bethanecol Study Group.
Ann Neurol. 1992 Nov;32(5):625-32. doi: 10.1002/ana.410320505.
4
Monoaminergic and cholinergic synaptic markers in the nucleus basalis of Meynert (nbM): normal age-related changes and the effect of heart disease and Alzheimer's disease.迈内特基底核(nbM)中的单胺能和胆碱能突触标记物:正常的年龄相关变化以及心脏病和阿尔茨海默病的影响
Ann Neurol. 1992 Jun;31(6):611-20. doi: 10.1002/ana.410310608.
5
Intralaminar neurochemical distributions in human midtemporal cortex: comparison between Alzheimer's disease and the normal.人类颞中回皮质层内神经化学分布:阿尔茨海默病与正常情况的比较。
J Neurochem. 1984 May;42(5):1402-10. doi: 10.1111/j.1471-4159.1984.tb02801.x.
6
Convergent cholinergic activities in aging and Alzheimer's disease.衰老与阿尔茨海默病中的胆碱能活动趋同。
Neurobiol Aging. 1992 May-Jun;13(3):393-400. doi: 10.1016/0197-4580(92)90113-c.
7
Reduced number of [3H]nicotine and [3H]acetylcholine binding sites in the frontal cortex of Alzheimer brains.阿尔茨海默病患者大脑额叶皮质中[3H]尼古丁和[3H]乙酰胆碱结合位点数量减少。
Neurosci Lett. 1986 Dec 3;72(1):115-9. doi: 10.1016/0304-3940(86)90629-4.
8
Cholinergic activity in autism: abnormalities in the cerebral cortex and basal forebrain.自闭症中的胆碱能活性:大脑皮层和基底前脑的异常。
Am J Psychiatry. 2001 Jul;158(7):1058-66. doi: 10.1176/appi.ajp.158.7.1058.
9
Bilateral symmetry of cholinergic deficits in Alzheimer's disease.阿尔茨海默病中胆碱能缺陷的双侧对称性
Arch Neurol. 1988 Mar;45(3):255-9. doi: 10.1001/archneur.1988.00520270029016.
10
Molecular forms of acetylcholinesterases in Alzheimer's disease.阿尔茨海默病中乙酰胆碱酯酶的分子形式
Fed Proc. 1986 Dec;45(13):2982-8.

引用本文的文献

1
Effects of Maternal Choline Supplementation on the Septohippocampal Cholinergic System in the Ts65Dn Mouse Model of Down Syndrome.孕期补充胆碱对唐氏综合征 Ts65Dn 小鼠模型中隔海马胆碱能系统的影响。
Curr Alzheimer Res. 2016;13(1):84-96. doi: 10.2174/1567205012666150921100515.
2
Functional and neurobiological similarities of aging in monkeys and humans.猴子与人类衰老的功能及神经生物学相似性
Age (Omaha). 1997 Jan;20(1):29-44. doi: 10.1007/s11357-997-0003-3.
3
Precuneus amyloid burden is associated with reduced cholinergic activity in Alzheimer disease.
顶内沟淀粉样蛋白负担与阿尔茨海默病胆碱能活性降低有关。
Neurology. 2011 Jul 5;77(1):39-47. doi: 10.1212/WNL.0b013e3182231419. Epub 2011 Jun 22.
4
Advances in understanding the mechanisms and management of persistent pain in older adults.老年人持续性疼痛的机制与管理研究进展
Br J Anaesth. 2008 Jul;101(1):111-20. doi: 10.1093/bja/aen090. Epub 2008 May 16.
5
Cholinergic forebrain degeneration in the APPswe/PS1DeltaE9 transgenic mouse.APPswe/PS1DeltaE9转基因小鼠中的胆碱能前脑变性
Neurobiol Dis. 2007 Oct;28(1):3-15. doi: 10.1016/j.nbd.2007.06.015. Epub 2007 Jun 27.
6
Aversive stimulus attenuates impairment of acquisition in a delayed match to position T-maze task caused by a selective lesion of septo-hippocampal cholinergic projections.厌恶刺激减弱了由隔海马胆碱能投射选择性损伤所导致的延迟位置匹配T迷宫任务中习得障碍。
Brain Res Bull. 2006 May 31;69(6):660-5. doi: 10.1016/j.brainresbull.2006.03.011. Epub 2006 Apr 18.
7
Reactive synaptogenesis in aging and Alzheimer's disease: lessons learned in the Cotman laboratory.衰老与阿尔茨海默病中的反应性突触形成:科特曼实验室的经验教训
Neurochem Res. 2003 Nov;28(11):1625-30. doi: 10.1023/a:1026048619220.
8
A role for the basal forebrain cholinergic system in estrogen-induced disinhibition of hippocampal pyramidal cells.基底前脑胆碱能系统在雌激素诱导的海马锥体细胞去抑制中的作用。
J Neurosci. 2003 Jun 1;23(11):4479-90. doi: 10.1523/JNEUROSCI.23-11-04479.2003.
9
Reorganization of cholinergic terminals in the cerebral cortex and hippocampus in transgenic mice carrying mutated presenilin-1 and amyloid precursor protein transgenes.携带突变早老素-1和淀粉样前体蛋白转基因的转基因小鼠大脑皮质和海马中胆碱能终末的重组
J Neurosci. 1999 Apr 1;19(7):2706-16. doi: 10.1523/JNEUROSCI.19-07-02706.1999.
10
Deficits in iodine-labelled 3-quinuclidinyl benzilate binding in relation to cerebral blood flow in patients with Alzheimer's disease.阿尔茨海默病患者中碘标记的3-喹核醇基苯甲酸酯结合与脑血流量的关系缺陷。
Eur J Nucl Med. 1993 May;20(5):379-86. doi: 10.1007/BF00208995.